Drugs & Targets FDA approves sotorasib + panitumumab for KRAS G12C-mutated colorectal cancer January 17, 2025Vol.51 No.02
Drugs & Targets FDA approves acalabrutinib + bendamustine and rituximab for mantle cell lymphoma January 17, 2025Vol.51 No.02
Drugs & Targets FDA issues proposed rule to limit nicotine in cigarettes January 17, 2025Vol.51 No.02
Drugs & Targets FDA revokes authorization of Red No. 3 in food and ingested drugs January 17, 2025Vol.51 No.02
Drugs & Targets FDA grants Rare Pediatric Disease designation for THIO in pediatric high-grade gliomas January 17, 2025Vol.51 No.02
Drugs & Targets N-Power Medicine acquires Syapse to expand network for oncology clinical research, trials January 17, 2025Vol.51 No.02
Drugs & Targets MAIA Biotechnology, BeiGene announce clinical supply agreement January 17, 2025Vol.51 No.02
Drugs & Targets Caris, Ontada form collaboration to advance molecular research, cancer care January 17, 2025Vol.51 No.02
Drugs & Targets FDA issues draft guidance on including tissue biopsies in clinical trials January 10, 2025Vol.51 No.01
Drugs & Targets FDA approves Ensacove for ALK-positive locally advanced or metastatic NSCLC January 10, 2025Vol.51 No.01
